150 related articles for article (PubMed ID: 36509236)
21. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
[TBL] [Abstract][Full Text] [Related]
22. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
[TBL] [Abstract][Full Text] [Related]
23. Multicenter Evaluation of Survival and Toxicities of Hepatocellular Carcinoma following Radioembolization: Analysis of the RESiN Registry.
Frantz S; Matsuoka L; Vaheesan K; Petroziello M; Golzarian J; Wang E; Gandhi R; Collins Z; Brower J; Rachakonda VM; Du L; Kennedy AS; Sze DY; Lee J; Brown DB
J Vasc Interv Radiol; 2021 Jun; 32(6):845-852. PubMed ID: 33812981
[TBL] [Abstract][Full Text] [Related]
24. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Factors in Overall Survival of Patients with Unresectable Intrahepatic Cholangiocarcinoma Treated by Means of Yttrium-90 Radioembolization: Results in Therapy-Naïve Patients.
Reimer P; Virarkar MK; Binnenhei M; Justinger M; Schön MR; Tatsch K
Cardiovasc Intervent Radiol; 2018 May; 41(5):744-752. PubMed ID: 29344713
[TBL] [Abstract][Full Text] [Related]
26. Repeated Treatment with
Filippi L; Di Costanzo GG; Tortora R; Pelle G; Cianni R; Schillaci O; Bagni O
Cancer Biother Radiopharm; 2019 May; 34(4):231-237. PubMed ID: 30758985
[No Abstract] [Full Text] [Related]
27. Radiation Segmentectomy for the Treatment of Primary Hepatic Malignancies of the Caudate Lobe: A Case Series.
Arora M; Toskich BB; Lewis AR; Padula CA; Montazeri SA; Ritchie C; Frey G; Paz-Fumagalli R; McKinney JM; Devcic Z
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1485-1493. PubMed ID: 36028573
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 3 Different Therapeutic Particles in Radioembolization of Locally Advanced Intrahepatic Cholangiocarcinoma.
Wagemans MEHM; Kunnen B; Stella M; van Rooij R; Smits M; Bruijnen R; Lam MGEH; de Jong HWAM; Braat AJAT
J Nucl Med; 2024 Feb; 65(2):272-278. PubMed ID: 38176716
[TBL] [Abstract][Full Text] [Related]
30. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
31. Change in total lesion glycolysis and clinical outcome after (90)Y radioembolization in intrahepatic cholangiocarcinoma.
Filippi L; Pelle G; Cianni R; Scopinaro F; Bagni O
Nucl Med Biol; 2015 Jan; 42(1):59-64. PubMed ID: 25213104
[TBL] [Abstract][Full Text] [Related]
32. Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with
Hermann AL; Dieudonné A; Ronot M; Sanchez M; Pereira H; Chatellier G; Garin E; Castera L; Lebtahi R; Vilgrain V;
Radiology; 2020 Sep; 296(3):673-684. PubMed ID: 32602828
[TBL] [Abstract][Full Text] [Related]
33. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
Wu X; Heller M; Lokken RP; Fidelman N; Lam A
J Vasc Interv Radiol; 2023 May; 34(5):815-823.e1. PubMed ID: 36693521
[TBL] [Abstract][Full Text] [Related]
34. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T; Golfieri R; Pech M; Pfammatter T; Arnold D; Cianni R; Maleux G; Munneke G; Pellerin O; Peynircioglu B; Sangro B; Schaefer N; de Jong N; Bilbao JI; ;
Cardiovasc Intervent Radiol; 2021 Jan; 44(1):21-35. PubMed ID: 32959085
[TBL] [Abstract][Full Text] [Related]
35. Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
Soydal C; Kucuk ON; Bilgic S; Ibis E
Ann Nucl Med; 2016 Jan; 30(1):29-34. PubMed ID: 26370716
[TBL] [Abstract][Full Text] [Related]
36. Resin Versus Glass Microspheres for
Van Der Gucht A; Jreige M; Denys A; Blanc-Durand P; Boubaker A; Pomoni A; Mitsakis P; Silva-Monteiro M; Gnesin S; Lalonde MN; Duran R; Prior JO; Schaefer N
J Nucl Med; 2017 Aug; 58(8):1334-1340. PubMed ID: 28082436
[TBL] [Abstract][Full Text] [Related]
37. Real-Life Experience in the Treatment of Intrahepatic Cholangiocarcinoma by
Schaarschmidt BM; Kloeckner R; Dertnig T; Demircioglu A; Müller L; Auer TA; Santos DPD; Steinle V; Miederer M; Gebauer B; Radunz S; Kasper S; Weber M; Theysohn J
J Nucl Med; 2023 Apr; 64(4):529-535. PubMed ID: 36328487
[TBL] [Abstract][Full Text] [Related]
38. Predictability of the radiological response to Yttrium-90 transarterial radioembolization by dynamic magnetic resonance imaging-based radiomics analysis in patients with intrahepatic cholangiocarcinoma.
Ballı HT; Pişkin FC; Püren Yücel S; Sözütok S; Özgül D; Aikimbaev K
Diagn Interv Radiol; 2024 May; 30(3):193-199. PubMed ID: 36994655
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases.
Tomozawa Y; Jahangiri Y; Pathak P; Kolbeck KJ; Schenning RC; Kaufman JA; Farsad K
J Vasc Interv Radiol; 2018 Jun; 29(6):858-865. PubMed ID: 29724520
[TBL] [Abstract][Full Text] [Related]
40. PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
Clin Nucl Med; 2014 Nov; 39(11):944-50. PubMed ID: 25140563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]